Significance and treatment of asymptomatic bacteriuria during pregnancy
dc.contributor.author | Hall D.R. | |
dc.contributor.author | Theron G.B. | |
dc.contributor.author | Van Der Horst W. | |
dc.date.accessioned | 2011-05-15T16:16:43Z | |
dc.date.available | 2011-05-15T16:16:43Z | |
dc.date.issued | 1997 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Article | |
dc.identifier.citation | International Journal of Gynecology and Obstetrics | |
dc.identifier.citation | 57 | |
dc.identifier.citation | 2 | |
dc.identifier.issn | 00207292 | |
dc.identifier.other | 10.1016/S0020-7292(97)02819-1 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13906 | |
dc.subject | amoxicillin | |
dc.subject | cefradine | |
dc.subject | clavulanic acid | |
dc.subject | erythromycin | |
dc.subject | nalidixic acid | |
dc.subject | nitrofurantoin | |
dc.subject | sulfamethoxazole | |
dc.subject | article | |
dc.subject | asymptomatic bacteriuria | |
dc.subject | clinical trial | |
dc.subject | cohort analysis | |
dc.subject | drug efficacy | |
dc.subject | female | |
dc.subject | human | |
dc.subject | major clinical study | |
dc.subject | pregnancy | |
dc.subject | pregnancy complication | |
dc.subject | priority journal | |
dc.subject | Adult | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Bacterial Infections | |
dc.subject | Bacteriuria | |
dc.subject | Cohort Studies | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Pregnancy | |
dc.subject | Pregnancy Complications, Infectious | |
dc.subject | Treatment Outcome | |
dc.title | Significance and treatment of asymptomatic bacteriuria during pregnancy | |
dc.type | Article |